Hang Seng Indexes Company: Launches Four New Indices

According to an announcement by Hang Seng Indexes Company on April 30th, the company launched four new indexes today: Hang Seng Biotech Short Index, Hang Seng Biotech 2x Short Index, Hang Seng Biotech 2x Leverage Index, and Hang Seng Biotech Dividend Accumulation 2x Leverage Index. These new indexes aim to reflect the performance of short-selling or leveraged investment strategies based on the Hang Seng Biotechnology Index, with related strategies being executed daily according to predetermined leverage ratios.

Gelonghui FinanceApr 30 16:37

Guosen Securities: War-related risk aversion fades, with automotive industry share prices and fundamentals showing recovery.

The Guoxin Overseas Stock Selection Strategy portfolio has seen gains across the board. Notably, the ROE All-Weather Strategy recorded a significant increase of +3.2%.

Zhitong FinanceApr 12 13:54

A Sudden Comeback! A Comprehensive Review of Innovative Drug ETFs!

Illustrated Innovative Pharmaceutical Theme ETF

Gelonghui FinanceApr 4 11:35

Roberto Liu of the Hong Kong Exchange: The growth momentum of Hong Kong's biotechnology industry remains solid this year.

Roberto Luoboren stated that as the biotechnology market continues to expand, the tools available in Hong Kong for investment and risk management are also becoming increasingly diverse.

Zhitong FinanceMar 6 15:16

Hang Seng Indexes Company: Technology and biotechnology themes in Hong Kong stocks performed strongly in 2025, with the Hang Seng Dual Tech Index achieving its best performance since inception.

In 2025, the two major themes of technology and biotechnology stood out in the Hong Kong stock market, with the Hang Seng Tech Index ("Tech Index") and the Hang Seng Biotechnology Index ("HSBIO") both recording their best annual performance since the launch of the indices.

Zhitong FinanceFeb 4 14:05

Hang Seng Indexes Company: Future Focus on Three Key Development Directions to Expand Asset Management Scale Tracking Technology-related Indices

Looking ahead, there are three key directions for development: consolidating the market leadership position in the technology and biotechnology sectors, expanding the asset management scale tracking technology-related indices, and continuously broadening the biotechnology index to support diversified product development; actively promoting product innovation by exploring more applications of artificial intelligence in business operations, launching products that align closely with market trends and demands, and developing cross-market indices; continuing to advance business growth in overseas markets to help global investors seize investment opportunities in Hong Kong and mainland China.

Zhitong FinanceFeb 3 19:12